Rift Valley fever: biology and epidemiology by Wright, D, Kortekaas, J, Bowden, TA, Warimwe, GM

Using cross-species vaccination approaches to counter emerging infectious diseases by Warimwe, GM, Francis, MJ, Bowden, TA, Thumbi, SM, Charleston, B

Shielding and activation of a viral membrane fusion protein. by Halldorsson, S, Li, S, Li, M, Harlos, KPG, Bowden, TA, Huiskonen, JT

A key region of molecular specificity orchestrates unique ephrin-B1 utilization by Cedar virus by Pryce, R, Azarm, K, Rissanen, I, Harlos, K, Bowden, TA, Lee, B

Idiosyncratic Mòjiāng virus attachment glycoprotein directs a host-cell entry pathway distinct from genetically related henipaviruses. by Rissanen, AI, Ahmed, AA, Azarm, K, Beaty, S, Hong, P, Nambulli, S, Duprex, WP, Lee, B, Bowden, TA

Parallel evolution in the emergence of highly pathogenic avian influenza a viruses by Escalera-Zamudio, M, Golden, M, Gutiérrez, B, Thézé, J, Keown, JR, Carrique, L, Bowden, TA, Pybus, OG

Convergent immunological solutions to Argentine hemorrhagic fever virus neutralization by Zeltina, A, Krumm, SA, Sahin, M, Struwe, WB, Harlos, K, Nunberg, JH, Crispin, M, Pinschewer, DD, Doores, KJ, Bowden, TA

Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil by Faria, NR, Mellan, TA, Whittaker, C, da S Candido, D, Hulswit, RJG, Kraemer, MUG, Schnekenberg, RP, Bowden, TA, Dye, C, Pybus, OG

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation by Watanabe, Y, Berndsen, ZT, Raghwani, J, Seabright, GE, Allen, JD, Pybus, OG, McLellan, JS, Wilson, IA, Bowden, TA, Ward, AB, Crispin, M

Naturally acquired Rift Valley fever virus neutralizing antibodies predominantly target the Gn glycoprotein by Wright, D, Allen, ER, Clark, MHA, Gitonga, JN, Karanja, HK, Hulswit, RJG, Taylor, I, Biswas, S, Marshall, J, Mwololo, D, Muriuki, J, Bett, B, Bowden, TA, Warimwe, GM

Immunogenic recombinant Mayaro virus-like particles present natively assembled glycoprotein by Kim, YC, Watanabe, Y, Arlen-Celina, L, Song, X, de Oliveira Souza, R, Stass, R, Azar, SR, Rossi, SL, Claser, C, Kümmerer, BM, Crispin, M, Bowden, TA, Huiskonen, JT, Reyes-Sandoval, A

A protective monoclonal antibody targets a site of vulnerability on the surface of Rift Valley fever virus by Allen, ER, Krumm, SA, Raghwani, J, Halldorsson, S, Elliott, A, Graham, VA, Koudriakova, E, Harlos, K, Wright, D, Warimwe, GM, Brennan, B, Huiskonen, JT, Dowall, SD, Elliott, RM, Pybus, OG, Burton, DR, Hewson, R, Doores, KJ, Bowden, TA

Antibody evasion by the P.1 strain of SARS-CoV-2 by Dejnirattisai, W, Zhou, D, Supasa, P, Liu, C, Mentzer, AJ, Ginn, HM, Zhao, Y, Duyvesteyn, HME, Tuekprakhon, A, Nutalai, R, Wang, B, López-Camacho, C, Slon-Campos, J, Walter, TS, Skelly, D, Costa Clemens, SA, Naveca, FG, Nascimento, V, Nascimento, F, Fernandes da Costa, C, Resende, PC, Pauvolid-Correa, A, Siqueira, MM, Dold, C, Levin, R, Dong, T, Pollard, AJ, Knight, JC, Crook, D, Lambe, T, Clutterbuck, E, Bibi, S, Flaxman, A, Bittaye, M, Belij-Rammerstorfer, S, Gilbert, SC, Carroll, MW, Klenerman, P, Barnes, E, Dunachie, SJ, Paterson, NG, Williams, MA, Hall, DR, Hulswit, RJG, Bowden, TA, Fry, EE, Mongkolsapaya, J, Ren, J, Stuart, DI, Screaton, GR